Showing results (2421-2430 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|April 17, 2026
Developing French Population Tariffs for the ICECAP-A Using Best-Worst ScalingZexuan Wang, Jonathan Sicsic, Pauline ChauvinPharmacoeconomics|March 28, 2026
The Economic Burden of Duchenne Muscular Dystrophy: A Systematic ReviewErik Landfeldt, Maria Åberg, Luca Bello, et al.Pharmacoeconomics|April 16, 2026
Balancing Innovation and Access: Insights from AIM's Fair Pricing Model and Its Current and Future ApplicationsJocelijn Stokx, Anne Hendrickx, Kärt Veliste, et al.Pharmacoeconomics|October 28, 1999
Reconciling decision models with the real world. An application to anaemia of renal failureY C Shih, T L KaufPharmacoeconomics|August 6, 1993
Economic impact of cost-containment strategies in third party programmes in the US. Part IIC M Kozma, R M Schulz, W M Dickson, et al.Pharmacoeconomics|April 8, 1992
A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countriesB Leese, J Hutton, A MaynardPharmacoeconomics|August 5, 1998
Methodological quality of economic modelling studies. A case study with hepatitis B vaccinesT Jefferson, V DemicheliPharmacoeconomics|January 8, 1996
Clinical issues related to the costs of alcoholismM O Howard, R W McGuffin, A J Saxon, et al.Pharmacoeconomics|October 28, 1999
Measuring sensitivity in pharmacoeconomic studies. Refining point sensitivity and range sensitivity by incorporating probability distributionsM J NuijtenPharmacoeconomics|September 8, 2000
Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of applicationM Sculpher, E Fenwick, K ClaxtonPageof 336